Mammary Carcinoma Update 2019 - A continuing education series from the MCI Academy 2019

Prof. Dr. med. Michael Untch would like to invite you to an interactive and up-to-date event in Berlin on the 10th of August. The individual treatment of patients with breast cancer has evolved in recent years. In addition to advanced therapy in the established subgroups (hormone receptor and HER2 status), there are now therapies based on single molecular characteristics, such as PARP inhibitor therapy in patients with BRCA mutations. In addition, tests are presented that predict the effectiveness of therapy within subgroups.

Termin: 

10.08.2019 -  10.08.2019